Open an account

Clearpoint Neuro

CLPT · NASDAQ

$9.45+$0.28 (+3.05%)TodayMarket closed ·
Prev close $9.17

About CLPT

ClearPoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 172 full-time employees. The company went IPO on 2019-07-03. The company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The company provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. The company also offers IRRAflow active fluid-exchange system.

Employees
172
Headquarters
Solana Beach, California
Listed
Jul 3, 2019
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
clearpointneuro.com

CLPT key statistics

Market cap
288.26M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
818.30K
Volume
468.20K
Open price
$9.27
High today
$9.72
Low today
$9.19
52 Week high
$28.10
52 Week low
$8.27

Clearpoint Neuro (CLPT) at a glance

Clearpoint Neuro (CLPT) last traded at $9.45, with a market cap of 288.26M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $9.19 and $9.72. The current price is 2.8% above the day's low and 2.8% below its high.

Volume so far is 468.20K shares, below the average of 818.30K shares a day.

Over the past year Clearpoint Neuro has ranged from $8.27 to $28.10, and now sits 6% of the way up that range.

Clearpoint Neuro met or beat analyst EPS estimates in 0 of the last 8 quarters. In Q2 FY26 it reported -$0.38 per share against an estimate of -$0.2924.

The average analyst price target is $23.97, 153.7% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $23.97
Low
$22.22
Now
$9.45
High
$26.25

CLPT earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 8 quarters.

  1. Q3 FY24: reported -$0.18 per share against an estimate of -$0.1768
  2. Q4 FY24: reported -$0.20 per share against an estimate of -$0.1666
  3. Q1 FY25: reported -$0.22 per share against an estimate of -$0.1632
  4. Q2 FY25: reported -$0.21 per share against an estimate of -$0.204
  5. Q3 FY25: reported -$0.21 per share against an estimate of -$0.204
  6. Q4 FY25: reported -$0.26 per share against an estimate of -$0.204
  7. Q1 FY26: reported -$0.32 per share against an estimate of -$0.2788
  8. Q2 FY26: reported -$0.38 per share against an estimate of -$0.2924

CLPT news

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

  • Press releaseBusiness Wire

    CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Avi Kapoor

    Crude Oil Down Over 5%; McDonald's Earnings Top Views

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

Similar companies

Companies in the same industry as Clearpoint Neuro

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.